Effect of a serotonin depleting regimen of 3,4-methylenedioxymethamphetamine (MDMA) on the subsequent stimulation of acetylcholine release in the rat prefrontal cortex

Brain Research Bulletin

Volumn 69, Issue 4, 2006, Pages 382-387

  Nair, S G ^a   Gudelsky, G A ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

8 OH DPAT; In vivo microdialysis; Neurotoxicity; Stress

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; ACETYLCHOLINE; SEROTONIN;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DRUG EFFECT; IN VIVO STUDY; INJECTION; MALE; MICRODIALYSIS; NERVE STIMULATION; NEUROTOXICITY; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; STRESS; TAIL;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ACETYLCHOLINE; ANIMALS; MALE; MICRODIALYSIS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN AGENTS; SEROTONIN AGONISTS; STRESS, PSYCHOLOGICAL;

EID: 33646074023     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2006.01.011     Document Type: Article

References (36)

1. Acquas E., Marrocu P., Pisanu A., Cadoni C., Zernig G., Saria A., and DiChiara G. Intravenous administration of ecstasy (3,4-methylenedioxymethamphetamine) enhances cortical and striatal acetylcholine release in vivo. Eur. J. Pharmacol. 418 3 (2001) 207-211
2. Acquas E., Wilson C., and Fibiger H.C. Conditioned and unconditioned stimuli increase frontal cortical and hippocampal acetylcholine release: effects of novelty, habituation and fear. J. Neurosci. 16 9 (2001) 3089-3096
3. 1A receptor density and 8-OH-DPAT-induced hypothermia: blockade by drugs preventing 5-hydroxytryptamine depletion. Eur. J. Pharmacol. 346 2-3 (1998) 181-188
4. Aguirre N., Frechilla D., Garcia-Osta A., Lasheras B., and Del Rio J. Differential regulation by methylenedioxymethamphetamine of 5-hydroxytryptamine1A receptor density and mRNA expression in rat hippocampus, frontal cortex, and brainstem: the role of corticosteroids. J. Neurochem. 68 3 (1997) 1099-1105
5. Baumann M.H., Ayestas M.A., and Rothman R.B. Functional consequences of central serotonin depletion produced by repeated fenfluramine administration in rats. J. Neurosci. 18 21 (1998) 9069-9077
6. Berger-Sweeney J. The effects of neonatal basal forebrain lesions on cognition: towards understanding the developmental role of the cholinergic basal forebrain. Int. J. Dev. Neurosci. 16 7-8 (1998) 603-612
7. Broening H.W., Morford L.L., Inman-Wood S.L., Fukumura M., and Vorhees C.V. 3,4-Methylenedioxymethamphetamine (ecstasy)-induced learning and memory impairments depend on the age of exposure during early development. J. Neurosci. 21 9 (2001) 3228-3235
8. 1A-mediated facilitation of in vivo acetylcholine release in rat frontal cortex. Brain Res. 707 2 (1996) 320-323
9. Cotterill R.M. Cooperation of the basal ganglia, cerebellum, sensory cerebrum and hippocampus: possible implications for cognition, consciousness, intelligence and creativity. Prog. Neurobiol. 64 1 (2001) 1-33
10. Darvesh A.S., Shankaran M., and Gudelsky G.A. 3,4-Methylenedioxymethamphetamine produces glycogenolysis and increases the extracellular concentration of glucose in the rat brain. J. Pharmacol. Exp. Ther. 301 1 (2002) 138-144
11. Fischer H.S., Zernig G., Schatz D.S., Humpel C., and Saria A. MDMA (ecstasy) enhances basal acetylcholine release in brain slices of the rat striatum. Eur. J. Neurosci. 12 4 (2000) 1385-1390
12. Gartside S.E., McQuade R., and Sharp T. Effects of repeated administration of 3,4-methylenedioxymethamphetamine on 5-hydroxytryptamine neuronal activity and release in the rat brain in vivo. J. Pharmacol. Exp. Ther. 279 1 (1996) 277-283
13. Green A.R., Cross A.J., and Goodwin G.M. Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"). Psychopharmacology (Berl) 119 13 (1995) 247-260
14. Green A.R., O'shea E., and Colado M.I. A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response. Eur. J. Pharmacol. 500 1-3 (2004) 3-13
15. Gudelsky G.A., and Nash J.F. Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions. J. Neurochem. 66 1 (1996) 243-249
16. Laplante F., Stevenson C.W., Gratton A., Srivastava L.K., and Quirion R. Effects of neonatal ventral hippocampal lesion in rats on stress-induced acetylcholine release in the prefrontal cortex. J. Neurochem. 91 6 (2004) 1473-1482
17. Mark G.P., Rada P.V., and Shors T.J. Inescapable stress enhances extracellular acetylcholine in the rat hippocampus and prefrontal cortex but not the nucleus accumbens or amygdala. Neuroscience 74 3 (1996) 767-774
18. Matuszewich L., Filon M.E., Finn D.A., and Yamamoto B.K. Altered forebrain neurotransmitter responses to immobilization stress following 3,4-methylenedioxymethamphetamine. Neuroscience 110 1 (2002) 41-48
19. Mizoguchi K., Yuzurihara M., Ishige A., Sasaki H., and Tabira T. Effect of chronic stress on cholinergic transmission in rat hippocampus. Brain Res. 915 1 (2001) 108-111
20. S.G. Nair, G.A. Gudelsky, 3,4-Methylenedioxymethamphetamine (MDMA) induced acetylcholine release in the prefrontal cortex is mediated by serotonergic and dopaminergic mechanisms. Psychopharmacology (Berl) 184 (2) 182-189.
21. Neigh G.N., Arnold H.M., Sarter M., and Bruno J.P. Dissociations between the effects of intra-accumbens administration of amphetamine and exposure to a novel environment on accumbens dopamine and cortical acetylcholine release. Brain Res. 894 (2001) 354-358
22. Parrott A.C., Buchanan T., Scholey A.B., Heffernan T., Ling J., and Rodgers J. Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users. Hum. Psychopharmacol. 17 6 (2002) 309-312
23. Reneman L., Lavalaye J., Schmand B., de Wolff F.A., van den Brink W., den Heeten G.J., and Booij J. Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings. Arch. Gen. Psychiatry 58 10 (2001) 901-906
24. Sarter M., and Bruno J.P. Cognitive functions of cortical acetylcholine: toward a unifying hypothesis. Brain Res. Brain Res. Rev. 23 1-2 (1997) 28-46
25. Scheffel U., Szabo Z., Mathews W.B., Finley P.A., Dannals R.F., Ravert H.T., Szabo K., Yuan J., and Ricaurte G.A. In vivo detection of short- and long-term MDMA neurotoxicity-a positron emission tomography study in the living baboon brain. Synapse 29 2 (1998) 183-192
26. Schmidt C.J., Levin J.A., and Lovenberg W. In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain. Biochem. Pharmacol. 36 5 (1987) 747-755
27. Schmidt C.J., and Taylor V.L. Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine. Biochem. Pharmacol. 36 23 (1987) 4095-4102
28. Series H.G., Cowen P.J., and Sharp T. p-Chloroamphetamine (PCA), 3,4-methylenedioxy-methamphetamine (MDMA) and d-fenfluramine pretreatment attenuates d-fenfluramine-evoked release of 5-HT in vivo. Psychopharmacology (Berl) 116 4 (1994) 508-514
29. Shankaran M., and Gudelsky G.A. A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration. Psychopharmacology (Berl) 147 1 (1999) 66-72
30. Sprague J.E., Preston A.S., Leifheit M., and Woodside B. Hippocampal serotonergic damage induced by MDMA (ecstasy): effects on spatial learning. Physiol. Behav. 79 2 (2003) 281-287
31. Stengard K. Tail pinch increases acetylcholine release in rat striatum even after toluene exposure. Pharmacol. Biochem. Behav. 52 2 (1995) 261-264
32. Stone D.M., Johnson M., Hanson G.R., and Gibb J.W. A comparison of the neurotoxic potential of methylenedioxyamphetamine (MDA) and its N-methylated and N-ethylated derivatives. Eur. J. Pharmacol. 134 2 (1987) 245-248
33. Stone D.M., Stahl D.C., Hanson G.R., and Gibb J.W. The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain. Eur. J. Pharmacol. 128 1-2 (1986) 41-48
34. Thiel C.M., Huston J.P., and Schwarting R.K. Cholinergic activation in frontal cortex and nucleus accumbens related to basic behavioral manipulations: handling, and the role of post-handling experience. Brain Res. 812 1-2 (1998) 121-132
35. Wareing M., Fisk J.E., and Murphy P.N. Working memory deficits in current and previous users of MDMA ('ecstasy'). Br. J. Psychol. 91 (2000) 181-188
36. Wang X., Baumann M.H., Xu H., Morales M., and Rothman R. 34-Methylenedioxymethamphetamine administration to rats does not decrease levels of the serotonin transporter protein or alter its distribution between endosomes and the plasma membrane. J. Pharmacol. Exp. Ther. 314 3 (2005) 1002-1012